An Open-Label, Single-Dose, Parallel-Group Study to Assess the Pharmacokinetics of the Hydrocodone Bitartrate Extended-Release Tablet (15 mg) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Hydrocodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Cephalon
- 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development
- 30 Dec 2011 Actual patient number (16) added as reported by ClinicalTrials.gov.
- 30 Dec 2011 Actual end date (August 2011) added as reported by ClinicalTrials.gov.